中性粒细胞重塑DNA修复格局影响结直肠癌生存与治疗表型
肿瘤浸润中性粒细胞(PMNs)在结直肠癌(CRC)中通过miR-155下调RAD51导致同源重组(HR)缺陷,在低级别CRC中抑制肿瘤生长;但DNA双链断裂(DSB)积累诱导非同源末端连接(NHEJ),促进晚期CRC生存。PMN诱导的HR缺陷CRC表型(低RAD51低Ku70)对PARP1抑制剂奥拉帕利敏感,而高Ku70高NHEJ表型可被NHEJ抑制剂靶向。
要点
- PMNs通过miR-155下调RAD51诱导HR缺陷,低级别CRC生长受抑
- PMN介导的DSB积累诱导NHEJ,促进晚期CRC生存与生长
- 低RAD51低Ku70表型对奥拉帕利合成致死敏感,高Ku70高NHEJ表型可靶向NHEJ
核心结论
- 中性粒细胞对CRC DNA修复格局具有功能性双重调节作用,驱动两种可转化的治疗表型。
研究设计与样本
- 利用人散发性CRC活检、TCGA基因表达分析、肿瘤异种移植、小鼠CRC模型及DSB修复关键因子小分子抑制。
主要发现
- PMNs通过miR-155依赖下调RAD51促进低级别CRC的HR缺陷,减弱肿瘤生长。
- 中性粒细胞介导的DSB积累诱导NHEJ,支持晚期CRC生存和生长。
- 鉴定出PMN诱导的HR缺陷CRC表型:低RAD51低Ku70,对奥拉帕利敏感;高Ku70高NHEJ表型可被NHEJ抑制靶向。
临床怎么用
- 根据PMN诱导的HR缺陷表型(RAD51/Ku70水平)选择PARP1抑制剂奥拉帕利或NHEJ抑制剂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Tumor-infiltrating neutrophils (polymorphonuclear neutrophils [PMNs]) are a prominent feature of colorectal cancer (CRC), where they can promote cytotoxicity or exacerbate disease outcomes. We recently showed that in acute colon injury, PMNs can increase DNA double-strand break (DSB) burden and promote genomic instability via microRNA-dependent inhibition of homologous recombination (HR) repair. In this study, we aimed to establish whether in inflamed colon, neutrophils shape the DSB-repair responses to impact CRC progression and sensitivity/resistance to DNA-repair targeted therapy. METHODS: Human sporadic CRC biopsies, The Cancer Genome Atlas gene expression analyses, tumor xenografts, and murine CRC models, as well as small-molecule inhibition of key DSB-repair factors were leveraged to investigate changes in the DSB-repair landscape and identify unique CRC responses with/without tumor infiltration by PMNs. RESULTS: We reveal that neutrophils exert a functional dualism in cancer cells, driving temporal modulation of the DNA damage landscape and resolution of DSBs. PMNs were found to promote HR deficiency in low-grade CRC by miR-155-dependent downregulation of RAD51, thus attenuating tumor growth. However, neutrophil-mediated genotoxicity due to accumulation of DSBs led to the induction of non-homologous end-joining (NHEJ), allowing for survival and growth of advanced CRC. Our findings identified a PMN-induced HR-deficient CRC phenotype, featuring low RAD51 and low Ku70 levels, rendering it susceptible to synthetic lethality induced by clinically approved PARP1 inhibitor Olaparib. We further identified a distinct PMN-induced HR-deficient CRC phenotype, featuring high Ku70 and heightened NHEJ, which can be therapeutically targeted by specific inhibition of NHEJ. CONCLUSIONS: Our work delineates 2 mechanism-based translatable therapeutic interventions in sporadic CRC.
引用
- Bui TM, Butin-Israeli V, Wiesolek HL, et al. Neutrophils Alter DNA Repair Landscape to Impact Survival and Shape Distinct Therapeutic Phenotypes of Colorectal Cancer. Gastroenterology. 2021. PMID: 33753103. doi:10.1053/j.gastro.2021.03.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。